Sustained Ventricular Tachycardia as a Harbinger of Cardiac Amyloidosis.
Journal
The American journal of case reports
ISSN: 1941-5923
Titre abrégé: Am J Case Rep
Pays: United States
ID NLM: 101489566
Informations de publication
Date de publication:
07 Dec 2020
07 Dec 2020
Historique:
entrez:
7
12
2020
pubmed:
8
12
2020
medline:
15
5
2021
Statut:
epublish
Résumé
BACKGROUND Cardiac amyloidosis is an infiltrative cardiomyopathy caused by the extracellular deposition of insoluble precursor protein amyloid fibrils. These depositions of protein amyloid fibrils are found on the atria and ventricles and can cause a wide array of arrhythmias; however, sustained ventricular arrhythmias are quite uncommon. CASE REPORT A 71-year-old man with a history of hypertension developed a sudden onset of shortness of breath, profuse diaphoresis, lightheadedness, and presyncope. Upon emergency medical services' arrival, an initial electrocardiogram revealed wide complex tachycardia with a heart rate of 220 to 230 beats per min. He was subsequently given, in succession, magnesium, adenosine, and amiodarone with no change in heart rate or rhythm. Due to ongoing symptoms of diaphoresis and the development of dyspnea, he underwent direct current cardioversion and was converted from ventricular tachycardia to atrial fibrillation at controlled rates. A transthoracic echocardiogram and cardiac magnetic resonance imaging showed features suspicious for cardiac amyloidosis. A subsequent 99m technetium pyrophosphate single-photon emission computerized tomography scan revealed a grade 3 visual uptake and a heart-to-contralateral lung ratio of 1.92, consistent with transthyretin amyloidosis. The patient was treated with tafamidis and an implantable cardioverter-defibrillator for secondary prevention of ventricular arrhythmia. CONCLUSIONS This case highlights the need to consider cardiac amyloidosis in the differential diagnoses of patients with persistent ventricular arrhythmia and no prior history of heart disease.
Identifiants
pubmed: 33281182
pii: 927041
doi: 10.12659/AJCR.927041
pmc: PMC7733151
doi:
Substances chimiques
Amiodarone
N3RQ532IUT
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e927041Références
J Am Coll Cardiol. 2019 Feb 12;73(5):589-597
pubmed: 30732713
BMC Cardiovasc Disord. 2018 Dec 4;18(1):221
pubmed: 30509186
Circ Heart Fail. 2019 Sep;12(9):e006075
pubmed: 31480867
Circulation. 2012 Sep 4;126(10):1286-300
pubmed: 22949539
Amyloid. 2015;22(3):171-4
pubmed: 26123279
Hippokratia. 2008;12(4):236-9
pubmed: 19158968
Cell Mol Life Sci. 2020 Apr;77(7):1421-1434
pubmed: 31728576
Heart Rhythm. 2014 Jan;11(1):158-62
pubmed: 24121001
J Innov Card Rhythm Manag. 2018 Mar 15;9(3):3051-3057
pubmed: 32477799
Eur Heart J. 2015 Nov 1;36(41):2793-2867
pubmed: 26320108
JACC Clin Electrophysiol. 2020 Apr;6(4):351-361
pubmed: 32327068
Nat Commun. 2016 Feb 23;7:10787
pubmed: 26902880
J Clin Med. 2019 Feb 22;8(2):
pubmed: 30813263
J Nucl Cardiol. 2014 Feb;21(1):175-84
pubmed: 24162886
J Am Coll Cardiol. 2018 Oct 2;72(14):e91-e220
pubmed: 29097296
Neth Heart J. 2019 Nov;27(11):525-536
pubmed: 31359320
Clin Med (Lond). 2018 Apr 1;18(Suppl 2):s30-s35
pubmed: 29700090
Int J Cardiol. 2016 Nov 1;222:562-568
pubmed: 27513652
Heart. 2011 Jan;97(1):75-84
pubmed: 21148582